If you missed the chance to submit your abstract in the first round due to incomplete data, or you have exciting new research, this is your last chance to be included in a fantastic program filled with internationally distinguished speakers and innovative research and clinical practice.

The Late Breaking sessions are informative fast-paced 5-minute presentations. The sessions are dedicated to new information or important findings not fully available before the general abstract deadline. Presentations are five minutes and should have no more than five slides. This session is one of the most popular sessions at the conference.

Late Breaking presentations are held as a single stream, this is an opportunity to present to all conference delegates, and is a popular session at the conference.

Late Breaking Abstract Deadline: 11.59pm (AEST) Sunday 18 August 2019 (NO EXTENSIONS)

Please note that the Late Breaking Abstract deadline is not an extension of the general abstract submission deadline.

In order to standardise the abstract layout, we kindly ask you to read the abstract submission guidelines carefully and use the abstract template provided.

Notification regarding late breaking abstract's status (accepted or rejected) will be sent to the presenting author of the abstract by Friday 20 September 2019.

Abstracts will be accepted for oral and poster presentations.

Late Breaking Prize

APSAD has a sponsored prize for best Late Breaking Presentation delivered at the Conference. The person judged as preparing and delivering the Best Late Breaking Presentation receives a certificate and a book voucher valued at $100. The award will be announced at closure of the conference.

There will also be a certificate for the runner up and an honourable.

The Late Breaking Presentations are judged on the basis of original scientific importance or clinical or policy relevance, and clarity of presentation.

Presentation Types

The Scientific Advisory Committee welcomes the submission of Late Breaking Abstracts for presentation at the APSAD Hobart 2019 Conference for the following presentation types;

Presentation Type Time Allocated Description
Oral Presentation 5 minutes (maximum of 5 slides) Oral presentations on original research findings, case studies, completed projects and theoretical analyses. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge.
Poster Presentation Permanently displayed during the conference.
Authors must be standing with their posters during the dedicated Poster Session
Posters can present research, case studies, divisional projects, or clinical topics. A poster viewing session will take place for delegates to discuss the posters with their authors, along with a dedicated Post Tour.

The session is dedicated to late-breaking and unpublished findings and cannot be a revision of an abstract submitted during the general abstract submission process. Late Breaking abstracts, containing new information or important findings not (fully) available before the general abstract deadline, can be submitted until Sunday 18 August 2019. For information regarding types of presentations and abstract preparation guidelines please see the abstract guidelines.

Please note that the Late Breaking Abstract deadline is not an extension of the general abstract submission deadline.

Abstracts must be submitted by 11.59pm (AEST) Sunday 18 August 2018, there will be no extension to the submission closing date.

Abstract Templates

Abstracts must be submitted using the appropriate abstract template, please see the template options below;

Standard Abstract_TEMPLATE
Service Delivery Abstract_TEMPLATE

Please read the abstract guidelines carefully. Any abstracts that do not conform to the guidelines will not be considered.

The Scientific Advisory Committee may reallocate a presentation type on the basis of time, content, space available and applicability to the Conference themes.

Note: Abstract presenters will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible.

Disclosure of Interest/Ethical Statement

APSAD recognises the considerable contribution that industry partners make to professional and research activities. We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in publications and presentations.

For an example of a disclosure of interest/ethical statement please see below

"Dr Smith has received funding from Metabolism Corp. No pharmaceutical grants were received in the development of this study."

Note: If accepted into the program you will be requested to include a disclosure of interest slide into your presentation or include such statements in your poster.

Selection Criteria

Abstracts will be favoured at review if they incorporate:

  •     Completed rather than future work (i.e. final results),
  •     Original data of high quality,
  •     An analysis that extends existing knowledge,
  •     Clarity of methodology, analysis and presentation of results,
  •     Specific rather than general findings.

In balancing the program, the committee may require authors to present their work in an alternate format (e.g. as a poster rather than oral presentation).

Note: We encourage abstracts that are based on Indigenous issues be presented by Indigenous persons, or an Indigenous co-presenter be included. If this is not possible, please include some information as to whether any member of the Indigenous community in which the research is based was involved in development of the research protocol or in conducting the research. Where possible this applies to other population groups as well.

Themes for Submission

Authors must select one primary and one secondary theme of the following that their abstract relates to.

Addiction reconceptualised Adolescents / youth
Aetiology (including genetics) Alcohol
Blood-borne viruses (incl. STI) Cannabis
Children & families Coercive treatment
Cognitive impairment training Comorbidity
Consumers & peers Crime, justice & legal issues
Cross culture & international Drug monitoring/novel psychoactive -
Drug policy reform Ecstasy & emerging psychoactive substances
eHealth – behavioural change Epidemiology
First Peoples Gambling
Harms & harm reduction Health policy & reforms
Health services & systems Health, law & human rights
Heroin & opioids Injecting drug use
Innovative prescribing – medicinal cannabis, e-cigs, etc. LGBTIQ
Methamphetamine & psychostimulants Neuroscience
New technologies & e-interventions Older adults
Other AOD issues Overdose
Over the counter codeine rescheduling Pharmaceuticals (consumption)
Prescription opioid treatment Prevention & early intervention
Primary Care - pharmacy in primary care Prisons & prisoner health
Psychopharmacology & psychobiology Regional challenges & innovations
Social & community issues Special populations
Tobacco & Tobacco Cessation Translational research
Treatment & interventions Treatment settings
Well at Work Women & maternal issues
Workforce issues

Notification of Acceptance

Notifications of acceptance will be sent via e-mail to the submitting author by Friday 20 September 2019. Abstracts submitted for oral will also be considered and reviewed for a poster presentation.